Protecting Medical Devices, Equipment, and Healthcare Technology

BSKB is back for our sixth annual Medical Technology IP Webinar! This webinar covers current patent issues in medical technology and the healthcare field. We will discuss recent developments at the Patent Trial and Appeal Board and the Court of Appeals for the Federal Circuit and their effect on obtaining patent rights for medical technology. 

We will focus on medical-related inventions with a significant electronic, imaging, mechanical, data processing, chemical and biotechnological component to the invention.

The webinar will have native English and Japanese speakers; each lecturer being an attorney, U.S. patent agent or Japanese benrishi.  English and Japanese language slides will be provided. 

Date:

October 2, 2026 (Japan time)

Time:

9:30 am - 11:00 am (JST)

Location:

Zoom (link provided upon registration)

Cost:

FREE!

Register Now!

Who Should Attend?

  • In-house counsel, technical advisors, and IP Coordinators from Japanese law firms and companies working in the medical technology and/or healthcare field, with a specialization in intellectual property focusing on medical-related inventions with a significant mechanical, electrical or data processing component
     
  • Japanese Patent Attorneys, agents, and students who are interested in gaining a deeper understanding of how to prosecute patent applications in the medical technology field

 

*IMPORTANT: This webinar is intended for Japanese audiences, or those with a professional understanding of the Japanese language, as half of the webinar will be presented in Japanese! 

Topics Covered

  • Insulet Corp. v. EOFlow, Co. Ltd.
    • a Federal Circuit case that dismissed a jury award because Insulet did not timely assert a trade secret misappropriation claim directed to an insulin patch pump against EOFlow. The Federal Circuit’s decision focuses on what actions trigger the statute of limitations. Many of the actions considered by the Federal Circuit uniquely apply to medical devices.
  • Additional discussion on recent cases regarding 35 U.S.C. §101, as well as Artificial Intelligence as it relates to Obviousness.